NZ274912A - Process for the alkylation of amino acids - Google Patents
Process for the alkylation of amino acidsInfo
- Publication number
- NZ274912A NZ274912A NZ274912A NZ27491294A NZ274912A NZ 274912 A NZ274912 A NZ 274912A NZ 274912 A NZ274912 A NZ 274912A NZ 27491294 A NZ27491294 A NZ 27491294A NZ 274912 A NZ274912 A NZ 274912A
- Authority
- NZ
- New Zealand
- Prior art keywords
- process according
- amino acid
- acid
- reaction
- salt
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 57
- 238000000034 method Methods 0.000 title claims abstract description 52
- 238000005804 alkylation reaction Methods 0.000 title description 6
- 230000029936 alkylation Effects 0.000 title description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 44
- 150000003839 salts Chemical group 0.000 claims abstract description 21
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- 125000005843 halogen group Chemical group 0.000 claims abstract description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 6
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 5
- 150000003862 amino acid derivatives Chemical class 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims abstract description 5
- 239000012736 aqueous medium Substances 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 4
- 238000004064 recycling Methods 0.000 claims abstract 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 129
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 63
- 229960005261 aspartic acid Drugs 0.000 claims description 63
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 61
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 60
- 229940024606 amino acid Drugs 0.000 claims description 51
- 235000001014 amino acid Nutrition 0.000 claims description 50
- VKZRWSNIWNFCIQ-WDSKDSINSA-N (2s)-2-[2-[[(1s)-1,2-dicarboxyethyl]amino]ethylamino]butanedioic acid Chemical group OC(=O)C[C@@H](C(O)=O)NCCN[C@H](C(O)=O)CC(O)=O VKZRWSNIWNFCIQ-WDSKDSINSA-N 0.000 claims description 28
- 239000011541 reaction mixture Substances 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 19
- 229910052751 metal Inorganic materials 0.000 claims description 14
- 239000002184 metal Substances 0.000 claims description 14
- 150000001768 cations Chemical class 0.000 claims description 12
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 10
- 239000003513 alkali Substances 0.000 claims description 7
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 4
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 4
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 125000001246 bromo group Chemical group Br* 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 235000013922 glutamic acid Nutrition 0.000 claims description 4
- 239000004220 glutamic acid Substances 0.000 claims description 4
- 229910052723 transition metal Inorganic materials 0.000 claims description 4
- 150000003624 transition metals Chemical class 0.000 claims description 4
- 239000011701 zinc Substances 0.000 claims description 4
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical group CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical group CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims description 2
- -1 4-cyclohexyl Chemical group 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 230000002152 alkylating effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 41
- 239000000047 product Substances 0.000 description 30
- PAAZPARNPHGIKF-UHFFFAOYSA-N 1,2-dibromoethane Chemical compound BrCCBr PAAZPARNPHGIKF-UHFFFAOYSA-N 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 9
- 239000000920 calcium hydroxide Substances 0.000 description 9
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 9
- 235000011116 calcium hydroxide Nutrition 0.000 description 9
- 239000012452 mother liquor Substances 0.000 description 9
- 238000009835 boiling Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 229960002989 glutamic acid Drugs 0.000 description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 5
- 229960005190 phenylalanine Drugs 0.000 description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 235000011148 calcium chloride Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 229910001622 calcium bromide Inorganic materials 0.000 description 3
- WGEFECGEFUFIQW-UHFFFAOYSA-L calcium dibromide Chemical compound [Ca+2].[Br-].[Br-] WGEFECGEFUFIQW-UHFFFAOYSA-L 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000007086 side reaction Methods 0.000 description 3
- 239000012265 solid product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- VEFLKXRACNJHOV-UHFFFAOYSA-N 1,3-dibromopropane Chemical compound BrCCCBr VEFLKXRACNJHOV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- 238000001728 nano-filtration Methods 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 239000012465 retentate Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- ATWLRNODAYAMQS-UHFFFAOYSA-N 1,1-dibromopropane Chemical compound CCC(Br)Br ATWLRNODAYAMQS-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- COESHZUDRKCEPA-ZETCQYMHSA-N 3,5-dibromo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC(Br)=C(O)C(Br)=C1 COESHZUDRKCEPA-ZETCQYMHSA-N 0.000 description 1
- NYPYHUZRZVSYKL-ZETCQYMHSA-N 3,5-diiodo-L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC(I)=C(O)C(I)=C1 NYPYHUZRZVSYKL-ZETCQYMHSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960002188 dibromotyrosine Drugs 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 1
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005373 pervaporation Methods 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical group 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/38—Separation; Purification; Stabilisation; Use of additives
- C07C227/40—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939322648A GB9322648D0 (en) | 1993-11-03 | 1993-11-03 | Process for the production of s.s.e.d.d.s |
| PCT/GB1994/002397 WO1995012570A2 (en) | 1993-11-03 | 1994-11-02 | Alkylation of amino acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ274912A true NZ274912A (en) | 1997-10-24 |
Family
ID=10744563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ274912A NZ274912A (en) | 1993-11-03 | 1994-11-02 | Process for the alkylation of amino acids |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US5849948A (enExample) |
| EP (2) | EP0677037B1 (enExample) |
| JP (2) | JP2888494B2 (enExample) |
| AT (2) | ATE164829T1 (enExample) |
| AU (1) | AU683948B2 (enExample) |
| CA (1) | CA2151043C (enExample) |
| DE (2) | DE69409500T2 (enExample) |
| GB (2) | GB9322648D0 (enExample) |
| ID (1) | ID24668A (enExample) |
| IL (1) | IL111444A0 (enExample) |
| IN (1) | IN185844B (enExample) |
| MY (2) | MY119883A (enExample) |
| NZ (1) | NZ274912A (enExample) |
| TW (1) | TW381071B (enExample) |
| WO (1) | WO1995012570A2 (enExample) |
| ZA (1) | ZA948623B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9322648D0 (en) | 1993-11-03 | 1993-12-22 | Ass Octel | Process for the production of s.s.e.d.d.s |
| US5554791A (en) * | 1994-07-11 | 1996-09-10 | Albemarle Corporation | Process for producing [S,S]-ethylenediamine-N,N'-disuccinic acid |
| GB9422761D0 (en) * | 1994-11-11 | 1995-01-04 | Ass Octel | Use of a compound |
| GB9422762D0 (en) * | 1994-11-11 | 1995-01-04 | Ass Octel | Use of a compound |
| GB9507659D0 (en) * | 1995-04-13 | 1995-05-31 | Ass Octel | Alkylation process |
| WO1996035662A1 (en) * | 1995-05-09 | 1996-11-14 | Nitto Chemical Industry Co., Ltd. | Process for producing alkylenediaminediorganic acid and salts thereof |
| BR9610178A (pt) | 1995-08-30 | 1998-08-11 | Dow Chemical Co | Composição de detergente para lavanderia composição para lava-louças automático método para lavar tecidos processo para remover nox de um fluido método para deposição não elétrica de cobre e composição para quelar um mental |
| EP0783034B1 (en) | 1995-12-22 | 2010-08-18 | Mitsubishi Rayon Co., Ltd. | Chelating agent and detergent comprising the same |
| DE19620644A1 (de) | 1996-05-22 | 1997-11-27 | Ciba Geigy Ag | Verwendung von stickstoffhaltigen Komplexbildnern zur Desodorierung und antimikrobiellen Behandlung der Haut und textilen Fasermaterialien |
| US5731468A (en) * | 1997-04-03 | 1998-03-24 | The Dow Chemical Company | Preparation of disodium ethylenediamine-N,N'-disuccinate |
| GB9721394D0 (en) * | 1997-10-09 | 1997-12-10 | Ass Octel | Anti-microbial compound |
| CN1177809C (zh) * | 1998-08-12 | 2004-12-01 | 味之素株式会社 | 新型聚氨基酸衍生物 |
| EP1660433A2 (en) * | 2003-07-24 | 2006-05-31 | The Queen's Medical Center | Preparation and use of alkylating agents |
| KR101595614B1 (ko) | 2013-05-16 | 2016-02-18 | 코오롱인더스트리 주식회사 | 신규 산 이무수물, 이의 제조방법 및 이로부터 제조된 폴리이미드 |
| WO2022169930A1 (en) * | 2021-02-03 | 2022-08-11 | Spero Renewables, Llc | Integrated process for making diastereopure ethylenediamine disuccinic acid (edds) from ethylene and aspartic acid using bromine as an intermediate |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2564092A (en) * | 1948-05-12 | 1951-08-14 | Frederick C Bersworth | Poly-ethylene poly-amino acid compounds |
| US3077487A (en) * | 1959-06-17 | 1963-02-12 | Victor Chemical Works | Lower alkylene and lower alkylenephenylene-lower alkylene polyamine bis n, n'-lower alkylene di and tri carboxylic acids, esters, salts, and chelates |
| US3158636A (en) * | 1963-10-29 | 1964-11-24 | Ethyl Corp | Manufacture of mixed alkyllead compounds |
| US4299978A (en) * | 1979-04-04 | 1981-11-10 | Showa Denko Kabushiki Kaisha | Process for separating iminodiacetic acid from aqueous glycine solution |
| US4704233A (en) * | 1986-11-10 | 1987-11-03 | The Procter & Gamble Company | Detergent compositions containing ethylenediamine-N,N'-disuccinic acid |
| US5629020A (en) | 1994-04-22 | 1997-05-13 | Emisphere Technologies, Inc. | Modified amino acids for drug delivery |
| JP3034969B2 (ja) | 1991-03-01 | 2000-04-17 | 旭化成工業株式会社 | アンモニア、α−アミノ酸類またはα−ケト酸の高感度定量法および高感度定量用組成物 |
| WO1993005014A1 (en) | 1991-09-05 | 1993-03-18 | Pharno-Wedropharm Gmbh | Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them |
| GB9216409D0 (en) * | 1992-08-01 | 1992-09-16 | Procter & Gamble | Detergent compositions |
| GB9322648D0 (en) | 1993-11-03 | 1993-12-22 | Ass Octel | Process for the production of s.s.e.d.d.s |
| US5587512A (en) * | 1994-07-11 | 1996-12-24 | Albemarle Corporation | Process for obtaining [S,S]-ethylenediamine-n,n'-disuccinic acid from a salt solution of such acid and l-aspartic acid |
| US5550285A (en) * | 1994-07-11 | 1996-08-27 | Albemarle Corp | Method for producing calcium salts of [S,S]-ethylenediamine-N,N'-disuccinic acid |
| US5554791A (en) * | 1994-07-11 | 1996-09-10 | Albemarle Corporation | Process for producing [S,S]-ethylenediamine-N,N'-disuccinic acid |
| US5466867A (en) * | 1994-07-11 | 1995-11-14 | Albemarle Corporation | Method for producing [S,S]-ethylenediamine-N,N'-disuccinic acid from its calcium salt |
| US5660701A (en) | 1996-02-29 | 1997-08-26 | Bio-Rad Laboratories, Inc. | Protein separations by capillary electrophoresis using amino acid-containing buffers |
-
1993
- 1993-11-03 GB GB939322648A patent/GB9322648D0/en active Pending
-
1994
- 1994-10-28 IL IL11144494A patent/IL111444A0/xx not_active IP Right Cessation
- 1994-11-01 MY MYPI20002231A patent/MY119883A/en unknown
- 1994-11-01 MY MYPI94002899A patent/MY114136A/en unknown
- 1994-11-01 IN IN1059MA1994 patent/IN185844B/en unknown
- 1994-11-01 ID IDP20000376D patent/ID24668A/id unknown
- 1994-11-02 WO PCT/GB1994/002397 patent/WO1995012570A2/en not_active Ceased
- 1994-11-02 DE DE69409500T patent/DE69409500T2/de not_active Expired - Lifetime
- 1994-11-02 EP EP94931141A patent/EP0677037B1/en not_active Expired - Lifetime
- 1994-11-02 GB GB9513302A patent/GB2291423B/en not_active Expired - Fee Related
- 1994-11-02 JP JP7513083A patent/JP2888494B2/ja not_active Expired - Lifetime
- 1994-11-02 DE DE69422643T patent/DE69422643T2/de not_active Expired - Lifetime
- 1994-11-02 AU AU80017/94A patent/AU683948B2/en not_active Ceased
- 1994-11-02 AT AT94931141T patent/ATE164829T1/de not_active IP Right Cessation
- 1994-11-02 ZA ZA948623A patent/ZA948623B/xx unknown
- 1994-11-02 CA CA002151043A patent/CA2151043C/en not_active Expired - Fee Related
- 1994-11-02 US US08/481,286 patent/US5849948A/en not_active Expired - Lifetime
- 1994-11-02 EP EP96203178A patent/EP0765863B1/en not_active Expired - Lifetime
- 1994-11-02 NZ NZ274912A patent/NZ274912A/en not_active IP Right Cessation
- 1994-11-02 AT AT96203178T patent/ATE188686T1/de active
- 1994-11-03 TW TW083110156A patent/TW381071B/zh not_active IP Right Cessation
-
1998
- 1998-07-23 US US09/121,295 patent/US6075164A/en not_active Expired - Lifetime
- 1998-10-14 JP JP29262898A patent/JP3294559B2/ja not_active Expired - Fee Related
-
2000
- 2000-05-05 US US09/566,217 patent/US6278020B1/en not_active Expired - Lifetime
-
2001
- 2001-06-25 US US09/891,042 patent/US20020019566A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU683948B2 (en) | Alkylation of amino acids | |
| US6072083A (en) | Method for purifying branched chain amino acids | |
| EP0770056B1 (en) | A process for producing [s,s]-ethylenediamine-n,n'-disuccinic acid | |
| CA2377490C (en) | Alkylation of amino acids | |
| GB2316073A (en) | Alkylation of Amino Acids | |
| IE841258L (en) | L-aspartyl-l-phenylalanine methyl ester | |
| GB2343449A (en) | Alkylation of amino acids | |
| US5587512A (en) | Process for obtaining [S,S]-ethylenediamine-n,n'-disuccinic acid from a salt solution of such acid and l-aspartic acid | |
| US4699999A (en) | Method of preparing pure carboxylic acids | |
| US4052451A (en) | Preparation of calcium pantothenate | |
| EP0770057B1 (en) | Method for producing calcium salts of [s,s]-ethylenediamine-n,n'-disuccinic acid | |
| US5731468A (en) | Preparation of disodium ethylenediamine-N,N'-disuccinate | |
| JPH09194448A (ja) | 二分子のアミノ酸の連結によるジアミン型ポリアミノ酸の製造方法およびそれらを含む生分解性キレート剤 | |
| US5581009A (en) | Process for crystallization of L-phenylalanine monomethyl sulfate using added salt | |
| JP2503592B2 (ja) | α−アスパルチルフェニルアラニン誘導体の製造法 | |
| US5357043A (en) | Preparation of oligopeptide or amino acid alkyl ester.HCl salts | |
| GB2299809A (en) | Acid preparation by de-protection | |
| JPH10175930A (ja) | 多価アミノカルボン酸の製造方法 | |
| KR920003333B1 (ko) | α-L-아스파르틸-L-페닐알라닌 β-저급 알킬 에스테르의 제조방법 | |
| WO1996032371A1 (en) | Reductive alkylation process for the preparation of compounds containing at least two amino groups |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |